Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) shares fell 8% after the company announced its intention to offer $400 million in convertible senior notes due 2031 in a private placement to qualified ...

In recent days, Dave Inc. completed a US$175,000,000 Rule 144A private offering of senior unsecured zero-coupon convertible notes due April 1, 2031, following the release of its fourth-quarter and ...

CHICAGO, December 02, 2025--(BUSINESS WIRE)--Exelon Corporation (Nasdaq: EXC) announced the pricing of its offering of $900 million aggregate principal amount of its 3.25% convertible senior notes due ...

The $550 million convertible senior notes offering was upsized from a previously announced offering of $350 million.

The gene-editing company said it intends to offer the convertible senior notes due 2031 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The ...

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) ("IREN”) today announced the pricing of its offering of $1 billion aggregate principal amount of 0.25% convertible senior notes ...

CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount of its convertible senior notes due 2031 (the “notes”) in a private ...

CRISPR Therapeutics AG (Nasdaq: CRSP) (the 'Company”) today announced its intention to offer, subject to market conditions ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...